xml:space="preserve">
Advertisement

Baltimore to share in $10 million investment in HIV research and care

A health care company called ViiV Healthcare, formed by the pharmaceutical giants GlaxoSmithKline and Pfizer, said this week that it would launch a four-year $10 million initiative in Baltimore and Jackson, Miss., to increase access to HIV treatment and services among gay black men.

The cities were chosen because of their high rates of infection among gay black men, and the number of new cases in the community.

Advertisement

Through the new initiative, called ACCELERATE!, the company will seek to identify the gaps and barriers to care through partnerships with local academic institutions.

The company said national research shows 1 in 3 black men who have sex with men are HIV-positive, compared with less than 1 in 10 white men who have sex with men. At the same time, 24 percent of the black men continue care and 16 percent suppress their viral loads, while 43 percent of white men stay in care and 34 percent achieve viral suppression.

Advertisement

Once research is conducted, officials said they will develop an approach to tackle the problems in each city.

Advertisement
YOU'VE REACHED YOUR FREE ARTICLE LIMIT

Don't miss our 4th of July sale!
Save big on local news.

SALE ENDS SOON

Unlimited Digital Access

$1 FOR 12 WEEKS

No commitment, cancel anytime

See what's included

Access includes: